Fatigue study using digital outcomes in multiple sclerosis and long COVID
Part of Brain & nervous system, Immune system & allergy, Infections, Lungs & breathing clinical trials.
This study is investigating fatigue using digital outcomes in people with multiple sclerosis, long COVID, and healthy volunteers. Participants must own a smartphone, be fluent in German or English, and be willing to provide informed consent. Exclusion criteria include having taken certain medications recently, being pregnant or lactating, or having additional health conditions that could affect fatigue or the autonomic nervous system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Confirmed diagnosis of MS or long COVID (for the patient group) OR healthy volunteer (for the healthy group)
- Smartphone ownership
- Willing and able to provide informed consent
- Fluent in German or English
- No use of medications affecting fatigue or autonomic nervous system (e.g., antidepressants) initiated or adjusted within the last month
- No pregnancy or lactation
- For MS patients: No additional comorbidities affecting fatigue or ANS (e.g., autoimmune or cardiovascular diseases)
- For long COVID patients: No additional comorbidities diagnosed before the first COVID infection that affect fatigue or ANS
- For healthy controls: No chronic disorders that may affect fatigue or ANS
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with multiple sclerosis over time using a smartphone app and clinic visits. It aims to better understand the disease and improve care.
This trial tests if a smartphone app and activity tracker can help reduce fatigue in people with Multiple Sclerosis. You will use the app and wear a small device to track your activity, while receiving support to manage your energy levels. The goal is to see if this helps more than standard care alone.
This study looks at how multiple sclerosis (MS) affects your thinking, sleep, and tiredness. It compares people with MS who have at least mild fatigue to people without MS who also have sleep problems, to understand these issues better.
This trial tests an online self-management program to help reduce fatigue in people with MS. You'll use a website or app over 24 weeks, and researchers will check how well it works.
This study tests a program to help reduce fatigue and other symptoms in people with Long COVID. It involves using an internet-connected device to access the program remotely.
This study uses a digital platform (app/website) to collect lifestyle and symptom information to better understand brain inflammation. You may qualify if you have certain conditions like Long COVID, migraines, autoimmune disease, inflammatory gut issues, mood disorders, or if you are a healthy comparison person.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.